GlaxoSmithkline Pharmaceuticals Limited announced that the Board of Directors at its meeting held on 7th April, 2017 appointed Mr. Subesh Williams and Mr. Marc Jones as Non-Executive Directors of the company with effect from April 7, 2017. Subesh Williams is Sr. Vice President, Global Corporate Development at GSK plc, a role he was appointed to in September 2013. In his current role, Subesh is responsible for M&A and Business Development across GSK's commercial businesses and has been involved in executing a number of transactions, including the creation of VIIV Healthcare and the 3 - part deal with Novartis which involved the acquisition of Novartis' vaccines business, the creation of a JV in Consumer Healthcare and the sale of GSK's oncology business. Marc Jones joined GSK plc in March 2017 as Sr. Vice President, Regional Pharma Supply. Marc joins GSK from AstraZeneca.